1. Home
  2. LRMR vs EAF Comparison

LRMR vs EAF Comparison

Compare LRMR & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • EAF
  • Stock Information
  • Founded
  • LRMR N/A
  • EAF 1886
  • Country
  • LRMR United States
  • EAF United States
  • Employees
  • LRMR N/A
  • EAF N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • EAF Industrial Machinery/Components
  • Sector
  • LRMR Health Care
  • EAF Energy
  • Exchange
  • LRMR Nasdaq
  • EAF Nasdaq
  • Market Cap
  • LRMR 183.8M
  • EAF 164.5M
  • IPO Year
  • LRMR N/A
  • EAF 1995
  • Fundamental
  • Price
  • LRMR $2.12
  • EAF $0.78
  • Analyst Decision
  • LRMR Strong Buy
  • EAF Hold
  • Analyst Count
  • LRMR 9
  • EAF 6
  • Target Price
  • LRMR $19.00
  • EAF $1.68
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • EAF 2.5M
  • Earning Date
  • LRMR 04-30-2025
  • EAF 04-25-2025
  • Dividend Yield
  • LRMR N/A
  • EAF N/A
  • EPS Growth
  • LRMR N/A
  • EAF N/A
  • EPS
  • LRMR N/A
  • EAF N/A
  • Revenue
  • LRMR N/A
  • EAF $514,037,000.00
  • Revenue This Year
  • LRMR N/A
  • EAF $0.09
  • Revenue Next Year
  • LRMR N/A
  • EAF $23.33
  • P/E Ratio
  • LRMR N/A
  • EAF N/A
  • Revenue Growth
  • LRMR N/A
  • EAF N/A
  • 52 Week Low
  • LRMR $1.61
  • EAF $0.52
  • 52 Week High
  • LRMR $11.20
  • EAF $2.53
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 44.72
  • EAF 55.62
  • Support Level
  • LRMR $2.03
  • EAF $0.57
  • Resistance Level
  • LRMR $2.33
  • EAF $0.81
  • Average True Range (ATR)
  • LRMR 0.30
  • EAF 0.09
  • MACD
  • LRMR -0.01
  • EAF 0.03
  • Stochastic Oscillator
  • LRMR 11.21
  • EAF 87.72

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using novel cell-penetrating peptide technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.

Share on Social Networks: